Strikingly, we found that this trafficking defect could be rescued by the knockdown of the FTD risk factor Tmem106b. We also found that the expression of endogenous levels of mutant CHMP2B results in a reduction in LAMP2 structures at the neuronal soma. The gene discussed is CHMP2B; the disease is frontotemporal dementia.